Cyclosporin A-induced ocular flutter after marrow transplantation.
Ocular flutter is a rare neurologic condition occurring in patients suffering from viral encephalitis, intracranial neoplasia, paraneoplastic syndrome or intoxications. Neurotoxicity is a recognized complication of cyclosporin A (CsA) therapy, but ocular flutter has not been reported in association with CsA administration to date. We describe a 17-year-old female patient who developed ocular flutter 51 days after transplantation with marrow from an unrelated donor, for acute myeloid leukemia. After discontinuation of cyclosporin, which was given for prophylaxis of graft-versus-host disease, the clinical symptoms resolved within 3 weeks, but a slightly abnormal electrooculogram persisted for more than 10 months.
Apsner
R
R
Universitätsklinik für Innere Medizin III, Abteilung für Nephrologieund Dialyse, Vienna, Austria.
Schulenburg
A
A
Steinhoff
N
N
Keil
F
F
Janata
K
K
Kalhs
P
P
Greinix
H
H
D000208:Acute Disease; D000328:Adult; D016026:Bone Marrow Transplantation; D016572:Cyclosporine / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007951:Leukemia, Myeloid / Q000628:therapy*; D015835:Ocular Motility Disorders / Q000139:chemically induced* / Q000503:physiopathology; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D016572:Cyclosporine